ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652173 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652173; 2) Community: the network communities that were significantly associated with the response to NSC 652173; 3) Molecule: the relationships between components within communities and NSC 652173; 4) MDR: the compounds that were significantly associated with the NSC 652173.

NSC Compound Enrichment Correlation
NSC 294712 Lobolide 0.0454469012959173 -0.018057273
NSC 609699 Topotecan hydrochloride 0.0454469012959173 0.47368583
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.0454469012959173 0.098566495
NSC 651853 Null 0.0454469012959173 0.14386871
NSC 12097 Resorufine 0.0459335986102865 0.075815784
NSC 180973 Tamoxifen citrate 0.0459335986102865 -0.14101462
NSC 254677 Phomazarin 0.0459335986102865 0.15659409
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0459335986102865 0.11201132
NSC 295501 Camptothecin Derivative 0.0459335986102865 0.49405568
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0459335986102865 -0.15301142
Total:40  Current:35    [First] [Prev] [Next] [Last]